FOLH1 and nonpapillary renal cell carcinoma: Regarding potential differences in the diagnostic performance of PSMA-targeted PET/CT among ccRCC and non-ccRCC tumors, several studies observed an inferior accuracy as well as a poorer uptake of PSMA-targeting radiopharmaceuticals in non-ccRCC lesions than ccRCC [31,42].